Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema

PHASE1TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Diabetic Macular Edema
Interventions
BIOLOGICAL

MP0112

Single intravitreal injection of MP0112 in the study eye

Trial Locations (4)

21287

Wilmer Eye Institute, Baltimore

77030

Retina Consultants of Houston, Houston

78705

Retina Research Center, Austin

02114

Ophthalmic Consultants of Boston, Boston

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Molecular Partners AG

INDUSTRY

lead

Allergan

INDUSTRY